'AI WILL NOT REPLACE ME'

摘要

GENETIC TESTING GETS MOST OF THE attention when it comes to matching cancer patients to specific treatments. But the vast majority of diagnostic information used in selecting a cancer treatment today comes not from those tests, but from under the microscope of the pathologist, who examines tissue biopsies taken during surgery. Stanley Robboy, vice-chair for diagnostic pathology at the Duke University Cancer Center, spoke with Newsweek's David H. Freedman about how artificial intelligence is improving diagnoses-and why some doctors are reluctant to embrace it.